MEGen: A Physiologically Based Pharmacokinetic Model Generator
- PMID: 22084631
- PMCID: PMC3212724
- DOI: 10.3389/fphar.2011.00056
MEGen: A Physiologically Based Pharmacokinetic Model Generator
Abstract
Physiologically based pharmacokinetic models are being used in an increasing number of different areas. However, they are perceived as complex, data hungry, resource intensive, and time consuming. In addition, model validation and verification are hindered by the relative complexity of the equations. To begin to address these issues a web application called MEGen for the rapid construction and documentation of bespoke deterministic PBPK model code is under development. MEGen comprises a parameter database and a model code generator that produces code for use in several commercial software packages and one that is freely available. Here we present an overview of the current capabilities of MEGen, and discuss future developments.
Keywords: database; equation; generator; pharmacokinetic; physiologically based.
Figures
5760,
192,
57.6,
19.2, and
5.76 ppm. PBPK model exported in acslX Libero version 3.0.1.6.
Similar articles
-
An introduction to physiologically-based pharmacokinetic models.Paediatr Anaesth. 2016 Nov;26(11):1036-1046. doi: 10.1111/pan.12995. Epub 2016 Aug 23. Paediatr Anaesth. 2016. PMID: 27550716 Review.
-
Performance Assessment and Translation of Physiologically Based Pharmacokinetic Models From acslX to Berkeley Madonna, MATLAB, and R Language: Oxytetracycline and Gold Nanoparticles As Case Examples.Toxicol Sci. 2017 Jul 1;158(1):23-35. doi: 10.1093/toxsci/kfx070. Toxicol Sci. 2017. PMID: 28402537
-
Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction.PLoS Comput Biol. 2016 Feb 12;12(2):e1004495. doi: 10.1371/journal.pcbi.1004495. eCollection 2016 Feb. PLoS Comput Biol. 2016. PMID: 26871706 Free PMC article.
-
Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.Toxicol Sci. 2012 Mar;126(1):5-15. doi: 10.1093/toxsci/kfr295. Epub 2011 Nov 1. Toxicol Sci. 2012. PMID: 22045031
-
[Progress in methodology of establishing physiologically based pharmacokinetic models].Yao Xue Xue Bao. 2014 Jan;49(1):16-22. Yao Xue Xue Bao. 2014. PMID: 24783500 Review. Chinese.
Cited by
-
Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data.Front Pharmacol. 2023 Mar 23;14:1165770. doi: 10.3389/fphar.2023.1165770. eCollection 2023. Front Pharmacol. 2023. PMID: 37033641 Free PMC article.
-
Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using in silico, in vitro and human biomonitoring data.Front Pharmacol. 2023 Feb 20;14:1140852. doi: 10.3389/fphar.2023.1140852. eCollection 2023. Front Pharmacol. 2023. PMID: 36891271 Free PMC article.
-
Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, in vitro and Human Biomonitoring Data.Front Pharmacol. 2021 Sep 2;12:692442. doi: 10.3389/fphar.2021.692442. eCollection 2021. Front Pharmacol. 2021. PMID: 34539393 Free PMC article.
-
Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll® Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using In Silico, In Vitro, and Human Biomonitoring Data.Front Pharmacol. 2019 Nov 29;10:1394. doi: 10.3389/fphar.2019.01394. eCollection 2019. Front Pharmacol. 2019. PMID: 31849656 Free PMC article.
-
Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.Comput Toxicol. 2019 Feb;9:61-72. doi: 10.1016/j.comtox.2018.11.002. Comput Toxicol. 2019. PMID: 31008414 Free PMC article. Review.
References
-
- Barton H. A., Chiu W. A., Setzer R. W., Andersen M. E., Bailer A. J., Bois F. Y., Dewoskin R. S., Hays S., Johanson G., Jones N., Loizou G., Macphail R. C., Portier C. J., Spendiff M., Tan Y. M. (2007). Characterizing uncertainty and variability in physiologically-based pharmacokinetic (PBPK) models: state of the science and needs for research and implementation. Toxicol. Sci. 99, 395–40210.1093/toxsci/kfm100 - DOI - PubMed
-
- Brown R. P., Delp M. D., Lindstedt S. L., Rhomberg L. R., Beliles R. P. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13, 407–484 - PubMed
LinkOut - more resources
Full Text Sources
